ISTH 2020 Congress
Coagulation and Natural Anticoagulants » Microparticles
Theme Navigation
- ISTH 2020 Congress
- Coagulation and Natural Anticoagulants
- Microparticles
- Coagulation and Natural Anticoagulants
-
Abstract Number: PB0368
Adhesive Properties of Plasma-Circulating and Platelet-Derived Microvesicles
-
Abstract Number: PB0376
Characterisation of Plasma Microvesicles in Type 2 Diabetes mellitus Patients with and without Microalbuminuria
-
Abstract Number: PB0371
Effects of Chemotherapy on Extracellular Vesicles and Coagulation Activation in Advanced Colorectal Cancer Patients
-
Abstract Number: OC 05.4
Exogenous Microparticles Bearing Tissue Factor Improve Outcome After Collagenase-Induced Intracranial Hemorrhage
-
Abstract Number: PB0375
Expression of Circulating Microparticles Procoagulant Activity in Cirrhotic Patients
-
Abstract Number: PB0369
Granulocyte Microvesicles with a High Plasmin Generation Capacity Promote Clot Lysis and Improve Outcome in Septic Shock
-
Abstract Number: PB0367
Influence of Specific Therapy on Microparticle-Associated Thrombin Generation in Patients with Primary Myelofibrosis
-
Abstract Number: PB0364
Micropartical-Associated Thrombin Generation in Patients with Philadelphia-Negative Myeloproliferative Neoplasms
-
Abstract Number: PB0365
Microparticles Contribute to Hypercoagulation, but Not to Coagulation in Healthy Controls
-
Abstract Number: PB0366
miRNAs 126 and 223 in Microparticles from Patients with Coronary Ischemic Disease
-
Abstract Number: PB0372
Plasma Levels of Platelet-derived Microvesicles Are Associated with Future Risk of Venous Thromboembolism
-
Abstract Number: PB0370
Plasma Platelets Microparticles as a Biomarker of Thrombotic Event in Thrombotic Thrombocytopenic Purpura Patients
-
Abstract Number: PB0377
Procoagulant Microparticles Improve Hemostasis in Mice with Haemophilia A